These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4330569)

  • 1. [Clinical trials with a new synthetic ACTH of prolonged action: Cortrosine Depot].
    Libon JC; Borlée J
    Rev Bras Med; 1971 Apr; 28(4):185-7. PubMed ID: 4330569
    [No Abstract]   [Full Text] [Related]  

  • 2. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients.
    Benos SA; Koutsoukos A; Sotirakis I; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):178-86. PubMed ID: 4314190
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacodynamic evaluation of synthetic prolonged-action ACTH on the adrenal function of patients with hypothalamo-pituitary pathology. Comparative study of synthetic ACTH and extra-delayed-action gel].
    Artese R; De Laszlo MH; Molocznik I; Varela J; Guitelman A; Brussino M; Dickmann GH; Montes ME
    Prensa Med Argent; 1971 Jan; 57(46):2088-97. PubMed ID: 4326359
    [No Abstract]   [Full Text] [Related]  

  • 4. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. I. Adrenocorticotropic and pituitary responsiveness following long-term intermittent administration.
    Benos SA; Koutsoukos A; Braouzi H; Georgopoulos A; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):165-77. PubMed ID: 4314189
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of bronchial asthma with synthetic delayed-action corticotropin].
    Andersson E; Lorenzen J
    Nord Med; 1968 Aug; 80(32):1050-2. PubMed ID: 4301738
    [No Abstract]   [Full Text] [Related]  

  • 6. Elimination of severe height growth suppression caused by treatment with betamethasone after switching to ACTH-depot in chronic bronchial asthma.
    Moulaert AJ; Van Gemund JJ
    Helv Paediatr Acta; 1972 Apr; 21(1):55-62. PubMed ID: 4336638
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synthetic depot-ACTH, plasmacortisol levels, and asthmatic syndrome (author's transl)].
    Illig H; Giesen HK
    Med Klin; 1975 Feb; 70(9):377-9. PubMed ID: 164616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthetic depot-ACTH in the treatment of obstructive bronchial diseases].
    Frank A
    Wien Med Wochenschr; 1971 Nov; 121(47):844-8. PubMed ID: 4331890
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cortrosyn depot for treatment of asthmatic children].
    Schook JE; Schüller CF
    Ned Tijdschr Geneeskd; 1971 Aug; 115(34):1409-13. PubMed ID: 4327521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthetic delayed-action ACTH in bronchial asthma].
    Szimak J
    Wien Med Wochenschr; 1971 Feb; 121(6):96-9. PubMed ID: 4322589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-acting synthetic ACTH in the treatment of skin diseases].
    Couteaux-Dumont C; Lapiere CM
    Arch Belg Dermatol Syphiligr; 1971; 27(4):385-92. PubMed ID: 4340591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Letter: Observation of herpes zoster patients during ACTH (Synacten depot) treatment].
    Roesdahl H
    Ugeskr Laeger; 1974 Jun; 136(25):1398-9. PubMed ID: 4366486
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of synthetic ACTH (Synacthen depot) in the treatment of various forms of epilepsy in children].
    Brambilla F; Giardini M; Lenti C
    Riv Neurol; 1972; 42(6):542-51. PubMed ID: 4348763
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary observations concerning the use of a synthetic delayed-action corticostimulin derivative (CIBA 36.716-Ba) in patients with asthma].
    Buytendijk HJ; Maesen F
    Acta Tuberc Pneumol Belg; 1965; 56(3):234-43. PubMed ID: 4285039
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current perspectives in the control of bronchial asthma. Synacthen Depot].
    Cardoso R
    Hospital (Rio J); 1969 Oct; 76(4):1439-54. PubMed ID: 4312092
    [No Abstract]   [Full Text] [Related]  

  • 16. [ACTH therapy and peritumoral oedema (author's transl)].
    Brotchi J
    Acta Neurol Belg; 1976; 76(4):193-200. PubMed ID: 184640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of treatment with a synthetic corticotropic peptide, tetracosactide-retard].
    Deguillaume R
    Presse Med (1893); 1971 Jan; 79(6):233-5. PubMed ID: 4323028
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of gout attacks with synthetic delayed-action ACTH].
    Muzzolini M; Rosetto G; Compagnoni A
    Policlinico Med; 1970; 77(6):322-32. PubMed ID: 4331713
    [No Abstract]   [Full Text] [Related]  

  • 19. [The response of cortisol to depot synthetic ACTH stimulation].
    Pereda JM; Herrera JL; Ramos F; Vivanco F
    Rev Clin Esp; 1972 Jul; 126(1):25-8. PubMed ID: 4342938
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and hormonal evaluation of the corticotropic effect of delayed-action beta 1-24 tetracosapeptide].
    Strumia E; Bellucci Sessa M; Molinatti GM
    Minerva Med; 1970 Jan; 61(1):10-8. PubMed ID: 4324570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.